Association between genetic polymorphism in tumor necrosis factor-alpha gene and adverse effects of etanercept in rheumatoid arthritis patients
Background. Gene polymorphisms affect etanercept’s pharmacokinetics, pharmacodynamics, and side effects. This effect is evidenced by the extensive genetic variation in the drug’s targets. Objectives. This study aims to find the association between different genotypes of the promoter region of the TN...
Main Authors: | Samer Imad Mohammed, Munaf Hashim Zalzala, Faiq Isho Gorial |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2023-09-01
|
Series: | Romanian Journal of Rheumatology |
Subjects: | |
Online Access: | https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-03.pdf |
Similar Items
-
The Effect of TNF-Alpha Gene Polymorphisms At -376 G/A, -806 C/T, and -1031 T/C on The Likelihood of Becoming a Non-Responder to Etanercept in A Sample of Iraqi Rheumatoid Arthritis Patients
by: Samer Imad Mohammed, et al.
Published: (2022-12-01) -
Predictors of Response to (Etanercept) in the Treatment of Iraqi Patients with Active Rheumatoid Arthritis
by: Nizar A. Jassim
Published: (2015-04-01) -
Effectiveness of Combination of Leflunomide and Methotrexate compared to Etanercept in the Treatment of Rheumatoid Arthritis: A systematic review and meta-analysis
by: Rashin Iman, et al.
Published: (2021-07-01) -
Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
by: Jian Cao, et al.
Published: (2019-05-01) -
The Role of Anti-TNFα Therapy in the Amelioration of Disease Burden in Patients with Refractory Rheumatoid Arthritis
by: Madha Mohammed Sheet, et al.
Published: (2014-06-01)